| Literature DB >> 33214768 |
Arturo S Herrera1, Paola E Solís Arias1, María Del C A Esparza1, Luis F T Bernal1, Andrey D Bondarev1, Vladimir P Fisenko1, Vladimir N Chubarev1, Nina N Minyaeva1, Liudmila M Mikhaleva1, Vadim V Tarasov1, Siva G Somasundaram1, Cecil E Kirkland1, Gjumrakch Aliev1.
Abstract
BACKGROUND: The ability of the human body to produce metabolic energy from light modifies fundamental concepts of biochemistry.Entities:
Keywords: Melanin; energy; hydrogen; oxygen; prematurity; retina; retinopathy of prematurity
Year: 2020 PMID: 33214768 PMCID: PMC7604751 DOI: 10.2174/1389202921999200417172817
Source DB: PubMed Journal: Curr Genomics ISSN: 1389-2029 Impact factor: 2.236
Fig. (1)Hematoxylin & Eosin (H&E) stained histological section of human retina. (A) The yellow star indicates the photoreceptor layer, devoid of blood vessels. The orange arrows indicate two blood vessels between the outer plexiform and the ganglion cell layers. (B) The same area under the higher resolution. (A higher resolution / colour version of this figure is available in the electronic copy of the article).
Fig. (3)Case study of a premature infant prescribed with QIAPI 1. (A) The patient on the first days after hospitalization, QIAPI 1 is given at least six times daily in the dose of three drops per ounce since Day 1; (B) The Intensive Care Unit setting; (C) The initial condition of the patient was poor, requiring continuous treatment. (A higher resolution / colour version of this figure is available in the electronic copy of the article).
Fig. (4)Case study of a premature infant prescribed with QIAPI 1 (cont’d). (A) The patient at age 4, still undergoing continuous treatment with QIAPI 1®; (B) The patient at age 9, showing signs of normal physical and mental development. QIAPI 1® had been given at least four times daily since birth. (A higher resolution / colour version of this figure is available in the electronic copy of the article).